Royal Bank of Canada’s Ariad Pharmaceuticals Inc ARIA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-47,187
| Closed | -$586K | – | 7046 |
|
|
2016
Q4 | $586K | Buy |
47,187
+7,008
| +17% | +$84.4K | ﹤0.01% | 3608 |
|
|
2016
Q3 | $550K | Sell |
40,179
-24,011
| -37% | -$241K | ﹤0.01% | 3640 |
|
|
2016
Q2 | $474K | Buy |
64,190
+14,373
| +29% | +$108K | ﹤0.01% | 3752 |
|
|
2016
Q1 | $318K | Sell |
49,817
-29,140
| -37% | -$163K | ﹤0.01% | 4020 |
|
|
2015
Q4 | $493K | Buy |
78,957
+23,347
| +42% | +$153K | ﹤0.01% | 3788 |
|
|
2015
Q3 | $324K | Buy |
55,610
+32,961
| +146% | +$254K | ﹤0.01% | 3920 |
|
|
2015
Q2 | $187K | Sell |
22,649
-4,296
| -16% | -$38K | ﹤0.01% | 4419 |
|
|
2015
Q1 | $222K | Sell |
26,945
-58,207
| -68% | -$430K | ﹤0.01% | 4163 |
|
|
2014
Q4 | $585K | Buy |
85,152
+58,341
| +218% | +$365K | ﹤0.01% | 3400 |
|
|
2014
Q3 | $145K | Buy |
26,811
+13,415
| +100% | +$78.3K | ﹤0.01% | 4408 |
|
|
2014
Q2 | $85K | Buy |
13,396
+2,340
| +21% | +$16.1K | ﹤0.01% | 4629 |
|
|
2014
Q1 | $89K | Sell |
11,056
-145,253
| -93% | -$1.13M | ﹤0.01% | 4609 |
|
|
2013
Q4 | $1.07M | Buy |
156,309
+147,319
| +1,639% | +$795K | ﹤0.01% | 2775 |
|
|
2013
Q3 | $165K | Buy |
8,990
+571
| +7% | +$11.1K | ﹤0.01% | 4199 |
|
|
2013
Q2 | $147K | Buy |
+8,419
| New | +$149K | ﹤0.01% | 4076 |
|
Other funds holding ARIA
Royal Bank of Canada's ARIA Position: Q1 2017 in Review
Royal Bank of Canada sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 47,187 shares — an estimated $586K sold.
Royal Bank of Canada first reported a position in ARIA in Q2 2013 and held it in 15 quarters. The position peaked at $1.07M in Q4 2013. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.
- Royal Bank of Canada reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
- Royal Bank of Canada sold 47,187 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $586K.
- Royal Bank of Canada first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 15 quarters.
- Royal Bank of Canada's Ariad Pharmaceuticals Inc position peaked at $1.07M in Q4 2013.
- 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.
Based on Royal Bank of Canada's 13F filing for Q1 2017, filed 15 May 2017.